Compounds > efavirenz--emtricitabine--tenofovir-disoproxil-fumarate-drug-combination

efavirenz--emtricitabine--tenofovir-disoproxil-fumarate-drug-combination and Obesity

efavirenz--emtricitabine--tenofovir-disoproxil-fumarate-drug-combination has been researched along with Obesity* in 1 studies

Other Studies

1 other study(ies) available for efavirenz--emtricitabine--tenofovir-disoproxil-fumarate-drug-combination and Obesity

ArticleYear
Loss of control of HIV viremia associated with the fat malabsorption drug orlistat.
    AIDS research and human retroviruses, 2012, Volume: 28, Issue:9

    Topics: Adenine; Adult; Anti-HIV Agents; Anti-Obesity Agents; Deoxycytidine; Drug Combinations; Drug Interactions; Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV; HIV Seropositivity; Humans; Lactones; Male; Nonprescription Drugs; Obesity; Organophosphonates; Orlistat; Oxazines; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load

2012